A large Greek pharmaceutical company is looking for manufacturers of the generic medications Leuprorelin and Triptorelin. The company wishes to conclude distribution agreement under licensing for medicines that conform with EU standards.
The prominent Greek pharmaceutical company began its activities in 1974. The company aims to provide high quality medicines at affordable prices. The company offers more than 150 different pharmaceutical products. It has an expanding presence in the domestic and international market. The company’s annual investments in research represent approximately 7% of the turnover. As a result, the company has established partnerships with leading companies in Europe and all over the world. Today the company has more than 500 employees.
The company is interested in establishing business collaboration with manufacturers of generic pharmaceutical products for the following medicines:
The Greek company would like to conduct a distribution services and license agreement with the producer of the aforementioned medicinal products, for the Greek market.
- Type of partner sought: The Greek pharmaceutical company is interested in products with available EU CTD (Common Technical Document). Products under development could be also considered.
- Specific area of activity of the partner: The Greek company would like to reach a distribution services and license agreement with pharmaceutical companies manufacturing Leuprorelin and Triptorelin generics.
Already on the market
411 days ago - Guidance on Horizon 2020 funding if there's a no-deal Brexit